Get the Stockscreener App
0.00
100.00%
-0.50
After Hours:
.67
0.67
+
Tc Biopharm Holdings Plc Adr stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform. Harnessing the innate ability of GD-Ts has enabled the company to develop a range of clinical-stage cell therapies designed to combat cancer and viral infection.
See More
Previous Close:
$0.50
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$256.50K
Revenue:
$4.60M
Net Income/Loss:
$-6.25M
P/E Ratio:
0.00
EPS:
-70.6412
Net Cash Flow:
$-15.38M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$9.9944
Tc Biopharm Holdings Plc Adr Stock (TCBP) Company Profile
Name
Tc Biopharm Holdings Plc Adr
Sector
Industry
Phone
01414337557
Address
MAXIM 1, HOLYTOWN
Compare TCBP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TCBP
Tc Biopharm Holdings Plc Adr
|
0.00 | 256.50K | 4.60M | -6.25M | -15.38M | -70.64 |
|
ONC
Beigene Ltd Adr
|
228.38 | 25.07B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
438.65 | 109.14B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.27 | 36.39M | 0 | 0 | 0 | 0.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
594.32 | 56.98B | 14.09B | 4.50B | 2.96B | 39.28 |
|
VRNA
Verona Pharma Plc Adr
|
71.31 | 5.39B | 0 | -153.72M | -103.81M | -2.00 |
Tc Biopharm Holdings Plc Adr Stock (TCBP) Latest News
TC BioPharm To Present At H.C. Wainwright 25th Annual Global Investment Conference - Barchart.com
TC BioPharm Announces Closing Of $5.5 Million Public Offering - Barchart.com
United States shares higher at close of trade; Dow Jones Industrial Average up 0.08% - Investing.com India
TC BioPharm Transitions from Nasdaq to OTC Markets Amid Delisting Notice - TipRanks
TC BioPharm to be delisted from Nasdaq, moves to OTC Markets - Investing.com India
TC BioPharm to be delisted from Nasdaq, moves to OTC Markets By Investing.com - Investing.com South Africa
TCBP Announces Transition from Nasdaq to OTC Markets - Benzinga
TC BioPharm to cut workforce, outsource functions for savings By Investing.com - Investing.com South Africa
TC BioPharm to cut workforce, outsource functions for savings - Investing.com India
TC Biopharm executes non-binding LoI to acquire pharmaceutical company - TipRanks
What Lies Ahead For TC BioPharm (Holdings) plc ADR (NASDAQ: TCBP) In 2025? - Stocks Register
TC Biopharm completes initial Cohort B patient dosing in ACHIEVE trial - MSN
TC BioPharm Announces ADS Ratio Change - TipRanks
TC BioPharm (Holdings) plc ADR (TCBP) Stock: Uncovering 52-Week Market Trends - The InvestChronicle
TC BioPharm reports progress in AML treatment trial - Investing.com
TC BioPharm (Holdings) plc ADR (TCBP): A Technical Analysis - The News Heater
Ratios Reveal: Breaking Down TC BioPharm (Holdings) plc ADR (TCBP)’s Financial Health - The Dwinnex
Quarterly Snapshot: Quick and Current Ratios for ScanTech AI Systems Inc (STAI) - The Dwinnex
Upcoming Stock Splits This Week (February 10 to February 14) – Stay Invested - Markets Insider
Check Out TC BioPharm (Holdings) plc ADR (TCBP)’s Trade Data Rather Than the Analysts’ Views - SETE News
TC BioPharm's Major ADS Restructure: What This 1:20 Ratio Change Means For Your Holdings - Stock Titan
TC BioPharm (Holdings) plc ADR (TCBP) Stock: A Year of Highs and Lows in the Market - The InvestChronicle
TC Biopharm Faces Potential Nasdaq Delisting Due to Bid Price Non-Compliance - TipRanks
TC Biopharm Announces Special Stock Dividend and Temporary Trading Halt - TipRanks
TC BioPharm advances in acquisition strategy - Investing.com India
What Analysts Think About TC BioPharm (Holdings) plc ADR (NASDAQ: TCBP)’s Potential Raise - Stocks Register
TC BioPharm Approves Key Resolutions to Enhance Strategic Flexibility - TipRanks
No Stopping Argo Blockchain Plc ADR (NASDAQ: ARBK)’s Stock Plunged? - Stocks Register
NIO Inc ADR (NYSE: NIO) Stock Forecast: Could Pass $8 In A Year - Stocks Register
If You Don’t Buy Safe Pro Group Inc (NASDAQ: SPAI) Now, You’ll Regret It Later - Stocks Register
Would I Buy Opendoor Technologies Inc (NASDAQ: OPEN) Stock At Any Time In The Future? - Stocks Register
Tempest Therapeutics Inc (NASDAQ: TPST) Investors Should Be Worried About This. - Stocks Register
Where Do Analysts See Gamestop Corporation (NYSE: GME) Heading? - Stocks Register
Upcoming Stock Splits This Week (December 30 to January 3) – Stay Invested - Nasdaq
TC BioPharm Advances Strategic Financial Initiative with New ADS Offering - TipRanks
TC BioPharm Announces Key Shareholder Meeting - TipRanks
TC Biopharm files $100M mixed securities shelf - TipRanks
TC Biopharm Faces Financial Strains Amid Rising Costs - TipRanks
TC Biopharm awarded funding of $250,000 from G-Rex Grant Program - TipRanks
TC BioPharm advances cancer therapy trials, raises $8M - Investing.com
TC BioPharm denies Nasdaq delisting rumors - Investing.com
United States shares mixed at close of trade; Dow Jones Industrial Average down 0.80% - Investing.com India
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.80% - Investing.com
TC Biopharm announces artificial intelligene initiative with Carnegie Mellon - TipRanks
TCBP Announces Site Opening of Guys and St. Thomas Hospital - StockTitan
TC BioPharm to start preclinical studies on monkeypox therapy - Investing.com India
TC Biopharm doses five new patients in the ACHIEVE Phase 2b trial in UK - TipRanks
TC Biopharm Unveils New Pre-Funded Warrant - TipRanks
TC BioPharm Regains Nasdaq Compliance - TipRanks
TC BioPharm Regains Compliance with Nasdaq Listing Rule 5550(b) - StockTitan
Upcoming Stock Splits This Week (August 5 to August 9) – Stay Invested - Yahoo Finance
Tc Biopharm Holdings Plc Adr Stock (TCBP) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.54%
7.58%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):